FH Founders

FH Founders is a French holding company and investment vehicle representing the founding members and a group of private investors of FineHeart, a clinical-stage medical technology company. The entity's primary objective is the advancement and commercialization of FineHeart’s lead innovation, the FlowMaker, which is the world's first fully implantable cardiac output accelerator. Designed by a team of internationally renowned cardiac surgeons and electrophysiologists, the technology operates in synergy with the heart's natural contractions to provide physiological support for patients with advanced heart failure. FH Founders serves as a strategic stakeholder and long-standing shareholder, supporting the development of IP-protected cardiovascular solutions that aim to provide less invasive alternatives to traditional Left Ventricular Assist Devices (LVADs). The company is central to the project of structuring the European active implantable medical devices (AIMD) sector and enhancing healthcare sovereignty in cardiac rhythm management.